Interesting, page-58

"Based on measurements of live cells of breast, ovarian, prostrate and leukemia cancers, they have been able to detect down to 10,000 cancer cells using the first generation MRX™ system. In comparison, transvaginal ultrasound (TUV) requires at least one billion ovarian cancer cells and breast x-ray mammography requires more than 100 million cells to detect the presence of breast cancer. The inherent sensitivity of SPMR holds great promise for enabling earlier cancer detection and lower medical costs."

"The second generation Imagion Biosystems MRX™ instrument is designed to support both in vivo (live cells in live animal tissue) and in vitro(test tube or cultures) testing to further validate SPMR technology before moving to first in-human testing."